Expression and Initial Promoter Characterization of PCAN1 in Retinal Tissue and Prostate Cell Lines
DeWitte T. Cross(Washington University in St. Louis), J. K. Burmester(Marshfield Clinic), K. Q. Zhang(Marshfield Clinic), Douglas J. Reding(Ascension), J. M. Burke(Medical College of Wisconsin), Sherry A. Salzman(Cancer Genetics (United States)), William J. Catàlona(Northwestern University)
Cited by 5
Related Papers
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
|Controlled Clinical Trials|2000|1k
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
|New England Journal of Medicine|2012|1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996